KK
Kim Kelderman
DELAYED 1 MONTH
Director; Director, Chief Executive Officer
BIO-TECHNE Corp
CONMED Corp
Filings
3
Companies
2
Latest
Jul 28, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
BIO-TECHNE Corp
Kim Kelderman
Director, Chief Executive Officer
Option Exercise
$1.7M
35,000 sh
Jul 30 8:11 PM
Jul 28, 2026
—
BIO-TECHNE Corp
Kim Kelderman
Director, Chief Executive Officer
Option Exercise
$1.3M
26,692 sh
May 7 9:22 PM
May 5, 2026